Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04729985
NA

Diabetes Discharge Transitional CGM Study (DDT-CGM)

Sponsor: Intermountain Health Care, Inc.

View on ClinicalTrials.gov

Summary

Intervention group will receive brief diabetic education, CGM education and use and have a CGM placed before discharge. They will also sign up for "Cloud" access of their CGM data. A medical assistant will review their CGM data daily to make sure they are using the CGM adequately. The principal investigator will review the CGM data and call the patient for a brief phone evaluation of their glucoses and their transition from the hospital to outpatient care. The will be called 4 times between discharge and day 15 by the principal investigator. Standard treatment group will receive a blinded CGM to be reviewed 30 days after discharge. Reduction in hospitalizations and ER visits within the first 30 days is the primary outcome. Time in range, hypoglycemia, hyperglycemia and patient satisfaction will also be evaluated 30 days after discharge.

Official title: Daibetes Discharge Transitional CGM Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2021-06-01

Completion Date

2024-12-01

Last Updated

2024-02-26

Healthy Volunteers

Yes

Interventions

DEVICE

CGM device with diabetic education, CGM education and a follow up protocol.

Blind CGM placed and recorded for 14 days after discharge and data downloaded

Locations (1)

Logan Regional Hospital

Logan, Utah, United States